Progress in Research on the Involvement of Intestinal Flora in Depression Based on the “Microbial-Gut-Brain” Axis

被引：1
作者：
Xu J. [1 ]
Ma Y. [1 ]
Wang D. [1 ]
Zhang X. [1 ]
Yang X. [1 ]
Yu Y. [1 ]
Ma L. [1 ]
Tang M. [1 ]
Xu X. [1 ]
机构：
[1] Key Laboratory of Dairy Science, Ministry of Education, College of Food Science, Northeast Agricultural University, Harbin
来源：
Shipin Kexue/Food Science | 2023年 / 44卷 / 05期
关键词：
depression; intestinal flora; mental disorders; probiotics; microbiota-gut-brain” axis;
D O I：
10.7506/spkx1002-6630-20220311-132
中图分类号：
学科分类号：
摘要：
Depression is one of the most common mental disorders in modern society. The disease not only seriously harms people’s quality of life, but also brings a huge burden to families and society because of the high suicide rate and disability rate caused by it. Recent studies have shown that the intestinal flora plays an important role the occurrence and progression of depression and dysfunctional gut-brain communication may be an essential pathological mechanism of depression. The “microbiota-gut-brain” (MGB) axis allows the intestinal flora to participate in the two-way information exchange between the intestine and the brain. Most previous studies mainly focus on exploring the individual characteristics of the intestinal flora in patients with depression and the relationship between the intestinal flora and the occurrence of depression, revealing that maintaining a healthy intestinal flora may be a new idea for the prevention and treatment of depression in the future. This article summarizes recent progress in this research field. We hope that this review can provide insights into the action mechanism of anti-depressive agents from the perspective of the MGB axis, and also provide a reference for the application of probiotics in new depression treatments. © 2023 Chinese Chamber of Commerce. All rights reserved.
引用
收藏
页码：383 / 391
页数：8
相关论文
共 78 条
[1]  
TAIPALE H, REUTFORS J, TANSKANEN A, Et al., Risk and risk factors for disability pension among patients with treatment resistant depression: a matched cohort study, BMC Psychiatry, 20, 1, (2020)
[2]  
WANG C, PAN R, WAN X, Et al., Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China, International Journal of Environmental Research and Public Health, 17, 5, (2020)
[3]  
YONG S J, TONG T, CHEW J, Et al., Antidepressive mechanisms of probiotics and their therapeutic potential, Frontiers in Neuroscience, 13, (2020)
[4]  
BESTED A C, LOGAN A C, SELHUB E M., Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part I: autointoxication revisited, Gut Pathogens, 5, 1, (2013)
[5]  
DU Y, GAO X R, PENG L, Et al., Crosstalk between the microbiota-gut-brain axis and depression, Heliyon, 6, 6, (2020)
[6]  
LAI J, ZHANG P, JIANG J, Et al., New evidence of gut microbiota involvement in the neuropathogenesis of bipolar depression by TRANK1 modulation: joint clinical and animal data, Frontiers in Immunology, 12, (2021)
[7]  
RASTELLI M, CANI P D, KNAUF C., The gut microbiome influences host endocrine functions, Endocrine Reviews, 40, 5, pp. 1271-1284, (2019)
[8]  
TREMLETT H, BAUER K C, APPEL-CRESSWELL S, Et al., The gut microbiome in human neurological disease: a review, Annals of Neurology, 81, 3, pp. 369-382, (2017)
[9]  
TAMBURINI S, SHEN N, WU H C, Et al., The microbiome in early life: implications for health outcomes, Nature Medicine, 22, 7, pp. 713-722, (2016)
[10]  
YU M, JIA H, ZHOU C, Et al., Variations in gut microbiota and fecal metabolic phenotype associated with depression by 16S rRNA gene sequencing and LC/MS-based metabolomics, Journal of Pharmaceutical and Biomedical Analysis, 138, pp. 231-239, (2017)
12345678